ArticlePloS one2018

Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1.

Alfred L Yergey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.